Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 8,499

Sort by:

Overactive Bladder (Genitourinary Disorders) - Drugs In Development, 2021

US$ 2,000.00

Overactive Bladder (Genitourinary Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Overactive Bladder - Drugs In Deve...

July 2021 126 pages

Pancreatic Cancer (Oncology) - Drugs In Development, 2021

US$ 2,500.00

Pancreatic Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Drugs In Development, 2021, pr...

July 2021 5249 pages

Pancreatitis (Gastrointestinal) - Drugs In Development, 2021

US$ 2,000.00

Pancreatitis (Gastrointestinal) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatitis - Drugs In Development, 2021, prov...

July 2021 121 pages

Paroxysmal Nocturnal Hemoglobinuria (Hematology) - Drugs In Development, 2021

US$ 2,000.00

Paroxysmal Nocturnal Hemoglobinuria (Hematology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Paroxysmal Nocturnal Hemoglobi...

July 2021 176 pages

Peanut Allergy (Immunology) - Drugs In Development, 2021

US$ 2,000.00

Peanut Allergy (Immunology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peanut Allergy - Drugs In Development, 2021, provid...

July 2021 176 pages

Periodontitis (Mouth and Dental Disorders) - Drugs In Development, 2021

US$ 2,000.00

Periodontitis (Mouth and Dental Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Periodontitis - Drugs In Development...

July 2021 59 pages

Peritoneal Cancer (Oncology) - Drugs In Development, 2021

US$ 2,500.00

Peritoneal Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peritoneal Cancer - Drugs In Development, 2021, pr...

July 2021 2212 pages

Plasminogen Activator Inhibitor 1 - Drugs In Development, 2021

US$ 3,500.00

Plasminogen Activator Inhibitor 1 - Drugs In Development, 2021 SUMMARY Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) - Plasminogen activator inhib...

July 2021 74 pages

Polycystic Kidney Disease (Genitourinary Disorders) - Drugs In Development, 2021

US$ 2,000.00

Polycystic Kidney Disease (Genitourinary Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polycystic Kidney Disease -...

July 2021 172 pages

Polycystic Ovarian Syndrome (Women's and Male Health) - Drugs In Development, 2021

US$ 2,000.00

Polycystic Ovarian Syndrome (Women's and Male Health) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polycystic Ovarian Syndro...

July 2021 60 pages

Polycythemia Vera (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Polycythemia Vera (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polycythemia Vera - Drugs In Development, 2021, pr...

July 2021 142 pages

Post-Polycythemia Vera Myelofibrosis (PPV-MF) (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Post-Polycythemia Vera Myelofibrosis (PPV-MF) (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post-Polycythemia Vera...

July 2021 550 pages

Premature Labor (Tocolysis) (Women's and Male Health) - Drugs In Development, 2021

US$ 2,000.00

Premature Labor (Tocolysis) (Women's and Male Health) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Premature Labor - Drugs I...

July 2021 61 pages

Proliferative Diabetic Retinopathy (PDR) (Metabolic Disorder) - Drugs In Development, 2021

US$ 2,000.00

Proliferative Diabetic Retinopathy (PDR) (Metabolic Disorder) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Proliferative Dia...

July 2021 68 pages

Proliferative Vitreoretinopathy (PVR) (Ophthalmology) - Drugs In Development, 2021

US$ 2,000.00

Proliferative Vitreoretinopathy (PVR) (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Proliferative Vitreoretin...

July 2021 43 pages

Pseudomonas aeruginosa Pneumonia (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Pseudomonas aeruginosa Pneumonia (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pseudomonas aeruginosa Pn...

July 2021 36 pages

Psoriasis (Immunology) - Drugs In Development, 2021

US$ 2,500.00

Psoriasis (Immunology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriasis - Drugs In Development, 2021, provides an over...

July 2021 1178 pages

Pulmonary Arterial Hypertension (Cardiovascular) - Drugs In Development, 2021

US$ 2,000.00

Pulmonary Arterial Hypertension (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Arterial Hypertensio...

July 2021 426 pages

Pyelonephritis (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Pyelonephritis (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pyelonephritis - Drugs In Development, 2021...

July 2021 155 pages

Radiation Toxicity - Drugs In Development, 2021

US$ 2,000.00

Radiation Toxicity - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Radiation Toxicity (Radiation Sickness, Acute Radiation Synd...

July 2021 337 pages

Rectal Cancer (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Rectal Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rectal Cancer - Drugs In Development, 2021, provides a...

July 2021 417 pages

Resistant Pseudomonas aeruginosa Infections (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Resistant Pseudomonas aeruginosa Infections (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Resistant Pseu...

July 2021 53 pages

Retinopathy Of Prematurity (Ophthalmology) - Drugs In Development, 2021

US$ 2,000.00

Retinopathy Of Prematurity (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinopathy Of Prematurity - Drugs I...

July 2021 73 pages

Rett Syndrome (Central Nervous System) - Drugs In Development, 2021

US$ 2,000.00

Rett Syndrome (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rett Syndrome - Drugs In Development, 20...

July 2021 163 pages

Rhabdomyosarcoma (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Rhabdomyosarcoma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rhabdomyosarcoma - Drugs In Development, 2021, prov...

July 2021 662 pages

Rhinovirus Infections (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Rhinovirus Infections (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rhinovirus Infections - Drugs In Dev...

July 2021 69 pages

Rosacea (Dermatology) - Drugs In Development, 2021

US$ 2,000.00

Rosacea (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rosacea - Drugs In Development, 2021, provides an overvie...

July 2021 107 pages

Schistosomiasis (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Schistosomiasis (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schistosomiasis - Drugs In Development, 20...

July 2021 41 pages

Severe Acute Respiratory Syndrome (SARS) (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Severe Acute Respiratory Syndrome (SARS) (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Severe Acute Resp...

July 2021 185 pages

Sickle Cell Disease (Hematology) - Drugs In Development, 2021

US$ 2,000.00

Sickle Cell Disease (Hematology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sickle Cell Disease - Drugs In Development, 20...

July 2021 386 pages

Sinusitis (Ear Nose Throat Disorders) - Drugs In Development, 2021

US$ 2,000.00

Sinusitis (Ear Nose Throat Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sinusitis - Drugs In Development, 2021, p...

July 2021 181 pages

Synovial Sarcoma (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Synovial Sarcoma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Synovial Sarcoma - Drugs In Development, 2021, prov...

July 2021 539 pages

Tetanus (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Tetanus (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tetanus - Drugs In Development, 2021, provides an...

July 2021 98 pages

Thalassemia (Hematology) - Drugs In Development, 2021

US$ 2,000.00

Thalassemia (Hematology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Drugs In Development, 2021, provides an...

July 2021 278 pages

Thyroid Cancer (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Thyroid Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thyroid Cancer - Drugs In Development, 2021, provides...

July 2021 1423 pages

Tinnitus (Ear Nose Throat Disorders) - Drugs In Development, 2021

US$ 2,000.00

Tinnitus (Ear Nose Throat Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tinnitus - Drugs In Development, 2021, pro...

July 2021 63 pages

Transmembrane Prolyl 4 Hydroxylase - Drugs In Development, 2021

US$ 3,500.00

Transmembrane Prolyl 4 Hydroxylase - Drugs In Development, 2021 SUMMARY Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) - Prolyl 4 hydroxylas...

July 2021 77 pages

Type 2 Angiotensin II Receptor - Drugs In Development, 2021

US$ 3,500.00

Type 2 Angiotensin II Receptor - Drugs In Development, 2021 SUMMARY According to the recently published report 'Type 2 Angiotensin II Receptor - Drugs In Development, 2021'; Type 2 Angiotensin II Rece...

July 2021 57 pages

Ulcerative Colitis (Gastrointestinal) - Drugs In Development, 2021

US$ 2,500.00

Ulcerative Colitis (Gastrointestinal) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ulcerative Colitis - Drugs In Development...

July 2021 941 pages

Uveal Melanoma (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Uveal Melanoma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Uveal Melanoma - Drugs In Development, 2021, provides...

July 2021 545 pages

Uveitis (Ophthalmology) - Drugs In Development, 2021

US$ 2,000.00

Uveitis (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Uveitis - Drugs In Development, 2021, provides an overv...

July 2021 288 pages

Viral Conjunctivitis (Ophthalmology) - Drugs In Development, 2021

US$ 2,000.00

Viral Conjunctivitis (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Viral Conjunctivitis - Drugs In Developmen...

July 2021 57 pages

Vitiligo (Dermatology) - Drugs In Development, 2021

US$ 2,000.00

Vitiligo (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vitiligo - Drugs In Development, 2021, provides an overv...

July 2021 203 pages

Women Infertility (Women's and Male Health) - Drugs In Development, 2021

US$ 2,000.00

Women Infertility (Women's and Male Health) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Women Infertility - Drugs In Develo...

July 2021 265 pages

Yellow Fever (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Yellow Fever (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Yellow Fever - Drugs In Development, 2021, pr...

July 2021 77 pages

Global Cephalosporin Drugs Market Size study, by Generation (First-generation, Second-generation, Third-generation, Fourth-generation, and Fifth-generation), by Prescription Type (Prescription Drugs and OTC Drugs), and Regional Forecasts 2021-2027

US$ 3,218.00

Global cephalosporin drugs market is valued approximately at $14.1 billion in 2020 and is anticipated to grow with a healthy growth rate of about 2.6% over the forecast period 2021-2027. Cephalosporin...

July 2021 200 pages

U.S. OTC Drugs Market - Industry Outlook & Forecast 2021-2026

US$ 3,750.00

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this U.S. OTC Drugs Market Report The U.S. OTC drugs market by revenue is expected to grow at a CAGR of 4.01% during th...

July 2021 180 pages

Investigation Report on China's Atorvastatin Market 2021-2025

US$ 2,600.00

Atorvastatin is a statin drug, which is used to lower blood cholesterol levels. This common drug is mainly used to treat high cholesterol, hyperlipidemia, and coronary heart disease. The original drug...

July 2021 50 pages

Investigation Report on China's Capecitabine Market 2021-2025

US$ 2,600.00

Capecitabine is a pyrimidine analog (pentoxycarbonyl-deoxy-cytosine nucleoside) that has anti-tumor activity to inhibit a variety of solid tumors, including breast and colon cancer. Capecitabine was d...

July 2021 50 pages

Investigation Report on China's Caspofungin Market 2021-2025

US$ 2,600.00

Caspofungin is the first echinocandin antifungal drug. It has a broad antibacterial spectrum, a long half-life, a high binding rate to human serum proteins, and a few adverse reactions. It is known as...

July 2021 50 pages

Filters

Clear all